We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Challenges Accuracy of 100 Patents Held by 10 Large Drugmakers
FTC Challenges Accuracy of 100 Patents Held by 10 Large Drugmakers
Ten major pharmaceutical companies will be receiving letters from the FTC challenging the accuracy or proper listing of more than 100 patents listed in the FDA’s Orange Book, which catalogs approved drugs with therapeutic equivalence evaluations.